Lenvima and Urticaria - a phase IV clinical study of FDA data
Summary:
Urticaria is reported as a side effect among people who take Lenvima (lenvatinib mesylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Keytruda, and have Endometrial cancer.
The phase IV clinical study analyzes which people have Urticaria when taking Lenvima. It is created by eHealthMe based on reports of 21,107 people who have side effects when taking Lenvima from the FDA, and is updated regularly.
What is Lenvima?
Lenvima has active ingredients of lenvatinib mesylate. eHealthMe is studying from 21,113 Lenvima users. Check the latest studies of Lenvima.
What is Urticaria?
Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,611 drugs and 2,956 conditions by eHealthMe. Check the latest studies of Urticaria.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
21,107 people reported to have side effects when taking Lenvima.
Among them, 53 people (0.25%) have Urticaria.

Among these 53 people:
How long have people been on Lenvima when they have Urticaria? *
- < 1 month: 58.62 %
- 1 - 6 months: 37.93 %
- 6 - 12 months: 3.45 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Urticaria when taking Lenvima? *
- female: 71.7 %
- male: 28.3 %
What is the age of people who have Urticaria when taking Lenvima? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 16.22 %
- 50-59: 13.51 %
- 60+: 70.27 %
What are other drugs people take besides Lenvima? *
- Keytruda: 17 people, 32.08%
- Afinitor: 9 people, 16.98%
- Amlodipine: 5 people, 9.43%
- Synthroid: 5 people, 9.43%
- Fexofenadine Hydrochloride: 4 people, 7.55%
- Oxycodone Hydrochloride: 4 people, 7.55%
- Norvasc: 3 people, 5.66%
- Neurontin: 3 people, 5.66%
- Vitamin D3: 2 people, 3.77%
- Fish Oil: 2 people, 3.77%
What are other side effects people have besides Urticaria? *
- Diarrhea: 21 people, 39.62%
- High Blood Pressure: 16 people, 30.19%
- Nausea (feeling of having an urge to vomit): 10 people, 18.87%
- Rashes (redness): 9 people, 16.98%
- Nausea And Vomiting: 9 people, 16.98%
- Dehydration (dryness resulting from the removal of water): 9 people, 16.98%
- Headache (pain in head): 6 people, 11.32%
- Thrombocytopenia (decrease of platelets in blood): 6 people, 11.32%
- Fatigue (feeling of tiredness): 6 people, 11.32%
- Itching: 5 people, 9.43%
What are the existing conditions these people have? *
- Endometrial Cancer: 24 people, 45.28%
- Renal Cell Carcinoma (a kidney cancer): 12 people, 22.64%
- Hepatocellular Carcinoma (liver cancer): 8 people, 15.09%
- High Blood Pressure: 8 people, 15.09%
- Thyroid Cancer: 5 people, 9.43%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 7.55%
- Joint Pain: 3 people, 5.66%
- Cancer Pain: 3 people, 5.66%
- Constipation: 3 people, 5.66%
- Abdominal Pain: 3 people, 5.66%
* Approximation only. Some reports may have incomplete information.
Do you take Lenvima and have Urticaria?
- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lenvima:
- Lenvima (21,113 reports)
Urticaria treatments and more:
- Urticaria (173,777 reports)
How severe was Urticaria and when was it recovered:
Expand to all the drugs that have ingredients of lenvatinib mesylate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lenvima:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Urticaria:
- Urticaria (2,611 drugs)
Browse all the conditions that are associated with Urticaria:
- Urticaria (2,956 conditions)
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lenvatinib mesylate (the active ingredients of Lenvima) and Lenvima (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Azelastine and Sodium Bicarbonate - now
- Could Temaz cause Withdrawal Syndrome? - 8 seconds ago
- Drug interactions of Ergocalciferol and Cabometyx - 12 seconds ago
- Drug interactions of Bystolic and Vitamins - 22 seconds ago
- Could Aredia cause Procedural Complication? - 22 seconds ago
- Could Doxorubicin Hydrochloride cause Dyspnea Exacerbated? - 22 seconds ago
- Could Terazosin Hydrochloride cause Abdominal Pain Aggravated? - 24 seconds ago
- Drug interactions of Verapamil Hydrochloride and Lovenox - 27 seconds ago
- Drug interactions of Aspirin and Piperacillin - 28 seconds ago
- Drug interactions of Jakafi and Restasis - 33 seconds ago